TODAY'S CHARTS: Aetna pops on CVS deal; BAC surges on tax bill; Disney and Fox talks back on?
Aetna, BAC and Disney are today's stocks to watch.
Luminar Technologies, a maker of lidar sensors for self-driving cars, said on Tuesday that Tesla was the largest customer for its sensors in the first quarter, accounting for more than 10% of its total revenue of $21 million during the period. Tesla's electric vehicles that are sold do not use lidars and it is not clear where Tesla used the sensors.
Social Security payments may be subject to cuts. Here's what the timing looks like.
The popular growth investor added to these three existing positions on Tuesday.
High net worth individuals (HNWIs) are those who have at least $1 million in easily convertible assets like cash, stocks, and bonds. They often manage significant wealth across diverse portfolios. As per Empower’s financial dashboard, retirement accounts such as 401(k) plans and IRAs comprise 55% of total wealth for many HNWIs. This is a stark contrast to the median household. Pew Research Center reports that these accounts typically represent only 27% of the net worth of households where at lea
“Those people aren’t just being useless (and being coddled to think useless jobs actually matter—they don’t), but they are also taking money away from the rest of the workforce’s retirement programs.”
You won't believe the amount of money that the bottler intends to return to shareholders.
Investing in cheap stocks brings unique risks because there is usually a reason the companies are undervalued.
Uncertainty is the word of the day, in reference to the near-term economic future. Sentiment will hinge on the inflation numbers due out next week. March’s figure rose to 3.5%, and April’s job numbers showed a marked slowing in the labor market; that combination has stoked fears of stagflation. But – corporate earnings from Q1 are beating expectations, and the stock market has taken a turn for the better with the S&P 500 closing just below 5,200 yesterday. Economic strategists are still optimist
Prepare yourself for a big shock.
Teva stock surged Wednesday after the company beat first-quarter views and unveiled promising results from its schizophrenia drug study.